ConAgra Foods Inc., (CAG: chart), missed analysts’ forecasts for earnings of 29 cents a share. The company said Q1 earnings from continuing operations will be about 4 cents a share below last year''s results, primarily because of difficult comparisons in its commodity trading and merchandising operations.

McCormick & Co., (MKC: chart), spice and seasoning maker, announced that its fiscal Q2 profit advanced to 46 cents a share, from 31 cents a share in the year-ago period. Stock-based compensation expense reduced earnings per share by 2 cents. Actions related to restructuring increased earnings per share by 14 cents, the company said. Net sales grew to $639.9 million from $628.6 million. The company topped analysts expectations for a quarterly profit of 30 cents a share.

Biomet Inc., (BMET: chart), medical products firm, reported that Q4 net profit declined 5% to 40 cents a share despite 7% revenue growth. Adjusted for compensation to its ex-CEO and other items, it would have earned 46 cents a share, meeting analyst forecasts. Biomet added it remains comfortable with analyst guidance for Q1 earnings between 43 cents to 45 cents a share and fiscal year earnings forecasts between $1.85 and $1.95 a share.

Nike Inc., (NKE: chart), athletic gear maker, reported that its Q4 income fell 5% to $1.27 per share, from $1.30 per share in the year-ago period as heavy spending around the World Cup and the effects of higher raw materials costs hit its sales and margins. The company also blamed an arbitration ruling involving Converse. Sales rose 8% from the same period last year. If not for a 12% share charge for a $52.5 million settlement between its Converse subsidiary and a former licensee, Nike earnings would have been $1.39 per share, a penny off the estimate of $1.40 by analysts.